TNGX logo

Tango Therapeutics, Inc. (TNGX) Return On Equity

Annual ROE:

-57.58%-17.09%(-42.21%)
December 31, 2024

Summary

  • As of today, TNGX annual return on equity is -57.58%, with the most recent change of -17.09% (-42.21%) on December 31, 2024.
  • During the last 3 years, TNGX annual ROE has fallen by -27.20% (-89.53%).
  • TNGX annual ROE is now -89.53% below its all-time high of -30.38%, reached on December 31, 2021.

Performance

TNGX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXprofitability metrics

Quarterly ROE:

-56.44%+17.97%(+24.15%)
September 30, 2025

Summary

  • As of today, TNGX quarterly return on equity is -56.44%, with the most recent change of +17.97% (+24.15%) on September 30, 2025.
  • Over the past year, TNGX quarterly ROE has dropped by -7.90% (-16.28%).
  • TNGX quarterly ROE is now -2666.67% below its all-time high of -2.04%, reached on June 30, 2020.

Performance

TNGX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNGXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TNGX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-42.2%-16.3%
3Y3 Years-89.5%-78.8%
5Y5 Years+57.2%-71.0%

TNGX ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-89.5%at low-78.8%+24.1%
5Y5-Year-89.5%+57.2%-123.0%+24.1%
All-TimeAll-Time-89.5%+57.2%-2666.7%+24.1%

TNGX ROE History

DateAnnualQuarterly
Sep 2025
-
-56.44%(+24.1%)
Jun 2025
-
-74.41%(-24.6%)
Mar 2025
-
-59.71%(-9.4%)
Dec 2024
-57.58%(-42.2%)
-54.57%(-12.4%)
Sep 2024
-
-48.54%(-4.6%)
Jun 2024
-
-46.42%(-2.6%)
Mar 2024
-
-45.23%(-8.4%)
Dec 2023
-40.49%(-11.2%)
-41.72%(-3.4%)
Sep 2023
-
-40.36%(+4.7%)
Jun 2023
-
-42.34%(-4.4%)
Mar 2023
-
-40.54%(-11.4%)
DateAnnualQuarterly
Dec 2022
-36.41%(-19.8%)
-36.39%(-15.3%)
Sep 2022
-
-31.57%(-2.6%)
Jun 2022
-
-30.76%(-16.8%)
Mar 2022
-
-26.34%(+3.0%)
Dec 2021
-30.38%(+77.4%)
-27.16%(-7.3%)
Sep 2021
-
-25.31%(+49.2%)
Jun 2021
-
-49.82%(+5.3%)
Mar 2021
-
-52.62%(+1.1%)
Dec 2020
-134.64%
-53.22%(-61.3%)
Sep 2020
-
-33.00%(-1517.6%)
Jun 2020
-
-2.04%

FAQ

  • What is Tango Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. annual ROE year-on-year change?
  • What is Tango Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Tango Therapeutics, Inc.?
  • What is Tango Therapeutics, Inc. quarterly ROE year-on-year change?

What is Tango Therapeutics, Inc. annual return on equity?

The current annual ROE of TNGX is -57.58%

What is the all-time high annual ROE for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high annual return on equity is -30.38%

What is Tango Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, TNGX annual return on equity has changed by -17.09% (-42.21%)

What is Tango Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of TNGX is -56.44%

What is the all-time high quarterly ROE for Tango Therapeutics, Inc.?

Tango Therapeutics, Inc. all-time high quarterly return on equity is -2.04%

What is Tango Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, TNGX quarterly return on equity has changed by -7.90% (-16.28%)
On this page